Article
Variants at the endocannabinoid receptor CB1 gene (CNR1) and insulin sensitivity, type 2 diabetes, and coronary heart disease.
Obesity (Silver Spring, Md.) - 1 Oct 2011
de Miguel-Yanes Jose M, Manning Alisa K, Shrader Peter, McAteer Jarred B, Goel Anuj, Hamsten Anders, Fox Caroline S, Florez Jose C, Dupuis Josée, Meigs James B
Abstract excerpt
Inhibition of the endocannabinoid receptor CB1 improves insulin sensitivity, lowers glycemia, and slows atherosclerosis. We analyzed whether common variants in the gene encoding CB1, CNR1, are associated with insulin resistance, risk of type 2 diabetes (T2D) or coronary heart disease (CHD). We studied 2,411 participants of the Framingham Offspring Study (mean age 60 years, 52% women) for quantitative traits and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
